Next Article in Journal
Meeting Cancer Detection Benchmarks in MRI/Ultrasound Fusion Biopsy for Prostate Cancer: Insights from a Retrospective Analysis of Experienced Urologists
Next Article in Special Issue
Long-Term Safety and Survival Outcomes of [225Ac]Ac-PSMA (Prostate-Specific Membrane Antigen) and [225Ac]Ac-/[177Lu]Lu-PSMA (TANDEM) Radioligand Therapy (PRLT) in Metastatic Castration-Resistant Prostate Cancer
Previous Article in Journal
Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib
Previous Article in Special Issue
Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients
 
 
Article

Article Versions Notes

Cancers 2025, 17(2), 279; https://doi.org/10.3390/cancers17020279
Action Date Notes Link
article xml file uploaded 16 January 2025 09:52 CET Original file -
article xml uploaded. 16 January 2025 09:52 CET Update https://www.mdpi.com/2072-6694/17/2/279/xml
article pdf uploaded. 16 January 2025 09:52 CET Version of Record https://www.mdpi.com/2072-6694/17/2/279/pdf
article html file updated 16 January 2025 09:57 CET Original file https://www.mdpi.com/2072-6694/17/2/279/html
Back to TopTop